Basic Information
Basic information for TMEM161B-AS1-230-11aa-1
Peptide Name TMEM161B-AS1-230-11aa-1
Genome Position chr5:88282073-88282105[+]
Species Human
Peptide Sequence MLVPCFYSLQN
Peptide Length 11
Unique No (TMEM161B-AS1-202-11aa,TMEM161B-AS1-204-11aa,TMEM161B-AS1-208-11aa,TMEM161B-AS1-211-11aa-2,TMEM161B-AS1-215-11aa-1,TMEM161B-AS1-216-11aa-1,TMEM161B-AS1-219-11aa,TMEM161B-AS1-225-11aa-1,TMEM161B-AS1-227-11aa-2,TMEM161B-AS1-229-11aa,TMEM161B-AS1-233-11aa,TMEM161B-AS1-235-11aa,TMEM161B-AS1-236-11aa,TMEM161B-AS1-237-11aa-1,TMEM161B-AS1-238-11aa-1,TMEM161B-AS1-240-11aa,TMEM161B-AS1-241-11aa-1,TMEM161B-AS1-245-11aa-1,TMEM161B-AS1-246-11aa,TMEM161B-AS1-248-11aa-2,TMEM161B-AS1-250-11aa,TMEM161B-AS1-251-11aa-2,TMEM161B-AS1-254-11aa-2,TMEM161B-AS1-255-11aa-3,TMEM161B-AS1-256-11aa-1,TMEM161B-AS1-257-11aa-8,TMEM161B-AS1-258-11aa-1)
Grand Average of Hydropathicity 0.7545
Relative Molecular Mass 1494.73
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000659215;TMEM161B-AS1-230
Transcript Length 2639
Coding Ability 0.4009
DNA Sequence Corresponding to Peptide ATGCTGGTGCCGTGCTTCTACAGCCTGCAGAAC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :